About Cytrellis Biosystems
Cytrellis Biosystems is a private company based in Woburn, Massachusetts. It has reported $82,722,421 raised in four offerings on Form D since December 2012.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 20, 2024 | Dec 31, 2024 | $25,132,486of $32.1M target | 15 | $1.6M | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 18, 2020 | Jan 4, 2021 | $49,999,998fully sold | 14 | $3.5M | EquityRule 506(b) | Form D ↗ |
| Feb 9, 2015 | Feb 20, 2015 | $7,139,937of $13.8M target | 21 | $339K | Equity, OptionsRule 506(b) | Form D ↗ |
| Nov 28, 2012 | Dec 12, 2012 | $450,000of $3.5M target | 3 | $150K | Debt, Options06 | Form D ↗ |
| Total, four offerings | $82,722,421 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cytrellis Biosystems's Form D filed Dec 31, 2024.
Earlier filings also listed Karen Cronholm (president and chief executive officer, director, last listed Jan 2021), Diane Marcou (executive officer, last listed Jan 2021), Keith Crandall (director, last listed Feb 2015), Douglas Levinson (chief executive officer and president, director, last listed Feb 2015), David Stone (executive officer, last listed Feb 2015), David Cruikshank (director, last listed Feb 2015), Amit Munshi (director, last listed Feb 2015) and R. Anderson (director, last listed Dec 2012).